In this article (Cancer Prev Res 2011;4;354–64), which was published in the March 2011 issue of Cancer Prevention Research (1), there was an erroneous entry for 2 data-points at the 4 g dose due to author error. Figure 2 in the article had 1 endpoint errantly deleted from the figure but not from statistical calculations. The means in Fig. 2 change slightly at the 4 g dose. The P value remains unchanged and the Aberrant Crypt Foci (ACF) change at the 2 g dose remains insignificant while still significant at the 4 g dose (P < 0.005). The corrected figure appears below.

1.
Carroll
RE
,
Benya
RV
,
Turgeon
DK
,
Vareed
S
,
Neuman
M
,
Rodriguez
L
, et al
Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
.
Cancer Prev Res
2011
;
4
;
354
64
.